Cystic Fibrosis (CFTR) Expanded Variant Panel | ARUP Laboratories Test Directory

Informed Consent for Genetic Testing (Required for NY patients)

Patient History Form for Cystic Fibrosis (CF) Testing

Additional Technical Information

Ordering Recommendation

Carrier screening for expectant individuals and those planning a pregnancy AND diagnostic testing for individuals with symptoms of classic CF.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Collect

Lavender (EDTA), pink (K₂EDTA).

Specimen Preparation

Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Plasma or serum. Specimens collected in sodium heparin, yellow (ACD solution), or lithium heparin tubes. Frozen specimens in glass collection tubes.

Remarks

Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: unacceptable

Methodology

Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry

Performed

Sun-Sat

Reported

5-10 days

Reference Interval

By report

Interpretive Data

Refer to report.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

81220

Are you an ARUP Client? Click here for your pricing.

Components

* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

CF Gene Mutation Panel
CF population carrier screening test
CF DNA Analysis
Cystic Fibrosis Genotyping
CF Molecular Genetic Testing
Classic CF

Cystic Fibrosis (CFTR) Expanded Variant Panel